Wednesday, June 22, 2016

Taking low-dose aspirin could increase cancer survival by 20 percent

Too much aspirin might be counter-productive because aspirin reduces the immune system.

http://www.eurekalert.org/pub_releases/2016-04/cu-tac041816.php

Public Release: 20-Apr-2016
Taking aspirin could increase cancer survival by 20 percent
Study prompts call for more research into aspirin as an additional cancer treatment
Cardiff University

Patients receiving cancer treatment could increase their chance of survival by up to 20% and help stop their cancer from spreading by taking a low-dose of aspirin, new research suggests.

In a systematic review of the available scientific literature a team from Cardiff University's School of Medicine found a significant reduction in mortality and cancer spread by patients who took a low-level dose of aspirin in addition to their cancer treatment (average study follow-up length over 5 years).

"There is a growing body of evidence that taking aspirin is of significant benefit in reducing some cancers," said Professor Peter Elwood who led the research published in the journal PLOS ONE.

"Whilst we know a low-dose of aspirin has been shown to reduce the incidence of cancer, its role in the treatment of cancer remains uncertain. As a result, we set out to conduct a systematic search of all the scientific literature."

•••••

"Our review, based on the available evidence, suggests that low-dose aspirin taken by patients with bowel, breast or prostate cancer, in addition to other treatments, is associated with a reduction in deaths of about 15-20%, together with a reduction in the spread of the cancer.

•••••

"One of the concerns about taking aspirin remains the potential for intestinal bleeding. That's why we specifically looked at the available evidence of bleeding and we wrote to all authors asking for further data. In no study was serious or life-threatening bleeding reported."

•••••

No comments:

Post a Comment